LSB (LakeShore Biopharma Co) Total Stockholders Equity : $85.15 Mil (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co Total Stockholders Equity?

LakeShore Biopharma Co's Total Stockholders Equity for the quarter that ended in Sep. 2024 was $85.15 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. LakeShore Biopharma Co's Book Value per Share for the quarter that ended in Sep. 2024 was $4.46. The ratio of a company's debt over equity can be used to measure how leveraged this company is. LakeShore Biopharma Co's Debt-to-Equity for the quarter that ended in Sep. 2024 was 0.61.

LakeShore Biopharma Co Total Stockholders Equity Historical Data

The historical data trend for LakeShore Biopharma Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co Total Stockholders Equity Chart

LakeShore Biopharma Co Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Total Stockholders Equity

-78.16

-110.17

105.71

81.26

LakeShore Biopharma Co Quarterly Data
	Mar21	Mar22	Jun22	Sep22	Mar23	Jun23	Sep23	Mar24	Sep24
Total Stockholders Equity	Get a 7-Day Free Trial				105.71	92.27	76.34	81.26	85.15

LakeShore Biopharma Co (NAS:LSB) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

LakeShore Biopharma Co's Book Value per Share for the quarter that ended in Sep. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(85.153	-	0)	/	19.081
	=	4.46

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

LakeShore Biopharma Co's Debt-to-Equity for the quarter that ended in Sep. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(40.94	+	11.149)	/	85.153
	=	0.61

LakeShore Biopharma Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of LakeShore Biopharma Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

LakeShore Biopharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

H6Z0:Germany

Address

38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629

Website

https://www.lakeshorebio.com

LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.